Customer support

xie@china-sinoway.com
EnglishEnglish
banner
Products
Home

Nano Active Series

Nanoactive Soy Isoflavones (ISO) 574-12-9

Nanoactive Soy Isoflavones (ISO) 574-12-9

5% by HPLC
  • Product Details

Product Information


Product name

NanoActive Soy isoflavones (ISO)

CAS No.

574-12-9

Quality Standard

5% by HPLC

Appearance

 Yellow, viscous and transparent liquid


COA of NanoActive Soy Isoflavones


ITEMS

STANDARDS

RESULTS

Characteristics

Light yellow, viscous liquid

conform

Diluted in water (1: 50)

Colorless or light yellow and transparent solution

conform

Odor

Characteristic Smell

conform

Assay (HPLC)

≥5.0%

5.10%

pH (in 1:50 aqueous solution)

5.0-8.0

6.8

Density (20ºC)

1.0 – 1.1 g/cm3

conform

Heavy Metal

≤10ppm

conform

Solubility

Soluble in water and oil, heated to over 40 ℃,

conform

dissolution rate will be accelerated

Total aerobic bacteria

< 10 CFU/g

conform

Molds and Yeasts

< 10 CFU/g

conform

pathogenic bacteria

negtive

conform

Conclusion:  Conformed to specification.


Usage



Isoflavone is one of the flavonoids, which mainly exist in legumes and is a class of secondary metabolites grown in soybeans. It is also called phytoestrogens because of its similar structure to estrogen. It can recover the deficiency of female estrogen secretion after 30 years old, improve skin moisture and elasticity, slow down menopause syndrome and improve osteoporosis, which regains female youthful charm. Soy isoflavones have been shown the functions of anti-aging, and hormone-like effect without side-effects. But because soy isoflavones are not water-soluble,

making it difficult to be used in cosmetics. NanoActive ISO is a new generation carrier of 4% soybean isoflavones, which turns soybean isoflavones into a completely water-soluble form. By improving solubility, NanoActive ISO could infiltrate into the skin easily, and play a comprehensive role of soy isoflavones
NanoActive ISO is the inclusion of 4% soy isoflavones in the polar lipid layer and lipophilic nuclei of sodium, with a particle size of less than 30nm developed by the nano-delivery system (NSD),  completely solve the problems of dissolution of isoflavones. soy isoflavones that stably wrapped in nano-carriers can greatly increase the absorption efficiency and bioavailability
NanoActive ISO IS Suitable for application in transparent hydrogels system.

Features of NanoActive Soy Isoflavones (ISO)

1. NanoActive Soy Isoflavones (ISO)  has good thermal, pH and shear stability, easy to use.|
2.NanoActive Soy Isoflavones (ISO) has significantly improved the stability and bioavailability of Soy Isoflavones (ISO).
3. NanoActive Soy Isoflavones (ISO) can greatly enhance the absorption.
4.NanoActive T Soy Isoflavones (ISO) is 100 % water soluble and 100% oil soluble (amphipathic) with the wide range of application.
5. The raw material of NanoActive Soy Isoflavones (ISO) meet the FDA GRAS standard


Product Efficacy:

Soy isoflavones have estrogen-like activity and have major skin benefits:
1. Remove oxygen free radical,anti-aging: promote skin cell metabolism, maintain skin elasticity. Prevent the mature skin from degeneration due to lack of hormones
2. Whitening: inhibit tyrosinase, weaken chloasma and black spots
3. Remove free radicals to fight oxidation and anti-skin aging
4. Remove wrinkles: promote collagen synthesis
5.Breast enhancement and Skin tightening: Phytoestrogens supplement the body's estrogen
6. Androgen inhibition: Reduce oil secretion (acne skin), inhibit hair growth (depilation) on the arms and legs and promote scalp hair growth (hair thinning)


NanoActive soy isoflavones increase skin thickness




Improve skin moisture



Improve skin firmness



Applications of NanoActive Soy Isoflavones (ISO):
Anti-wrinkle and anti-aging cream, whitening, removing spots, removing wrinkles, nourishing hair, hair growth, hair removal cream
Recommended Quantity: 1-3%, equal to 0.04-0.12% of soy isoflavones
Solubility: water and oil
PH: 2-6
Thermal stability: stable
Electrolyte stability: no known incompatibility
Operation suggestion: add water at 1:9 ratio and heat it up to 90℃ until it becomes the transparent solution. And then add it to the recipe.
Product storage: avoid light preservation under 25 ℃



Send A Message

If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.
Related Products

Ciclopirox Olamine
Ciclopirox Olamine 41621-49-2
97.5% up by HPLC; CEP/USP
phosphatidylserine
Phosphatidylserine (PS) 51446-62-9
20%, 50%, 70%, 90%, 98% up by HPLC
LIRAGLUTIDE
Liraglutide 204656-20-2
Product Information Product name Liraglutide Sequence H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu- Glu-Gly-Gln-Ala-Ala-Lys[N6-[N-(1-oxohexadecyl)-L-γ-glutamyl]- -Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH CAS No. 204656-20-2 Molecular Formula C172H265N43O51 Molecular Weight 3751.20 Storage  2~8℃ Appearance White to off-white crystalline powder COA of Liraglutide Test Specification Results Appearance: White to off-white crystalline powder or lumps White powder Identity: 3751.2±1.0 3751.1 Purity (By HPLC) : Not Less than 98.0%; 99.51% Residual solvents: ≤0.25%total; ≤0.1%individual; ≤0.01%CH2CN Complies Related Peptide Total Impurity ≤ 2.0% Largest Single Impurity ≤ 1.0% TI =0.41% LSI =0.25% Peptide Content: Not Less than 85.0% 87.7% Water (K.F.): Not more than 5% 4.2% Acetate acid: Not more than 10% 8.1% Bacterial Endotoxins Not more than 50IU/mg Complies Usage Function and Usage of Liraglutide 204656-20-2 1、 Type 2 diabetes Liraglutide improves control of blood glucose.It reduces meal-related hyperglycemia (for 24 hours after administration) by increasing insulin secretion (only) when required by increasing glucose levels, delaying gastric emptying, and suppressing prandial glucagon secretion. In common to various degrees with other GLP-1 receptor agonists, liraglutide has advantages over more traditional therapies for type 2 diabetes: ·         Liraglutide acts in a glucose-dependent manner, meaning it will stimulate insulin secretion only when blood glucose levels are higher than normal, preventing "overshoot". Consequently, it shows negligible risk of hypoglycemia. ·         Liraglutide has the potential for inhibiting apoptosis and stimulating regeneration of beta cells (seen in animal studies). ·         Liraglutide decreases appetite and inhibits body weight gain, as shown in a head-to-head study versus glimepiride. ·         Liraglutide lowers blood triglyceride levels. 2、Obesity Liraglutide has been approved as an injectable adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients. The specified criteria are an initial body mass index (BMI) of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight), in the presence of at least one weight-related comorbid condition (e.g.hypertension, type 2 diabetes mellitus, or dyslipidemia). In late 2014, data were reported from the SCALE™ Obesity and Prediabetes trial, which is a randomised, double-blind, placebo-controlled, multinational trial in non-diabetic people with obesity and non-diabetic people who are overweight with comorbidities. In this phase 3a trial, there were 3,731 participants randomised to treatment with liraglutide 3 mg or placebo, both in combination with diet and exercise. Those who completed the 56-week trial achieved an average weight loss of 9.2%, to be compared with a 3.5% reduction in the placebo group.
Send A Message
Send A Message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.

Home

Products

about

Contact